Results 81 to 90 of about 34,974 (164)

Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent inject® Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract

Clinical Ophthalmology, 2021
Inder Paul Singh,1 Steven Sarkisian Jnr,2 Dana Hornbeak,3 L Jay Katz,3,4 Thomas Samuelson5 for the iStent inject Study Group1The Eyes Centers of Racine & Kenosha, Racine, WI, USA; 2Oklahoma Eye Surgeons, Oklahoma City, OK, USA; 3Glaukos Corporation, San ...
Singh IP, Sarkisian Jnr S, Hornbeak D, Katz LJ, Samuelson T   +4 more
doaj  

IOP and glaucoma medication score: iStent eyes and inject W eyes.

IOP and glaucoma medication score: iStent eyes and inject W eyes.
Yoshihito Sakanishi (17904254), Nobuyuki Ebihara (805110), Shuu Morita (17904251), Satoshi Watanabe (103008), Ikari Riyu (17904257)   +4 more
core   +1 more source

A Nonrandomized, Comparative Case Series of Combined Phacoemulsification with iStent Inject W and OMNI Surgical System [PDF]

PurposeTo compare efficacy and safety outcomes of phacoemulsification combined with either iStent inject W or OMNI surgical system with different degrees of gonioscopy-assisted transluminal trabeculotomy (GATT) in patients with glaucoma.DesignSingle ...
Pradeesh, Navanandhanan, Masood, Imran, Salam, Aysha, Tiong, Ethan Wen Wei   +3 more
core   +1 more source

Characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling

Clinical Ophthalmology, 2014
Kendall S Hunter,1 Todd Fjield,2 Hal Heitzmann,2 Robin Shandas,1 Malik Y Kahook3 1Department of Bioengineering, University of Colorado Denver, Aurora, CO, USA; 2Glaukos Corporation, Laguna Hills, CA, USA; 3University of Colorado Hospital Eye Center ...
Hunter KS, Fjield T, Heitzmann H, Shandas R, Kahook MY   +4 more
doaj  

Comparison of changes in IOP and medication score at 12 months postoperatively: iStent eyes vs inject eyes.

Comparison of changes in IOP and medication score at 12 months postoperatively: iStent eyes vs inject eyes.
Yoshihito Sakanishi (17904254), Nobuyuki Ebihara (805110), Shuu Morita (17904251), Satoshi Watanabe (103008), Ikari Riyu (17904257)   +4 more
core   +1 more source

Efficacy and Safety of Kahook Dual Blade Goniotomy and Trabecular Micro-Bypass Stent in Combination with Cataract Extraction

Biomimetics
In recent years, rapid advancements in glaucoma research have led to the development of more effective treatments of this chronic and irreversible condition. Of these, Kahook Blade Dual (KDB) goniotomy and second-generation trabecular micro-bypass stent (
Kevin Y. Wu, Shu Yu Qian, Lysa Houadj, Michael Marchand   +3 more
doaj   +1 more source

Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification

Ophthalmology and Therapy, 2020
Introduction This study sought to assess ocular surface disease changes following cataract surgery combined with trabecular micro-bypass stent(s) implantation (iStent or iStent inject).
Justin A. Schweitzer, Whitney H. Hauser, Mitch Ibach, Brandon Baartman, Subba R. Gollamudi, Andrew W. Crothers, John E. Linn, John P. Berdahl   +7 more
doaj   +1 more source

Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma

Ophthalmology and Therapy, 2018
Introduction The aim of this study was to assess 36-month outcomes after cataract surgery and implantation of two second-generation trabecular micro-bypass stents (iStent inject, Glaukos Corporation, San Clemente, CA, USA) into eyes with predominantly ...
Fritz H. Hengerer, Gerd U. Auffarth, Christoffer Riffel, Ina Conrad-Hengerer   +3 more
doaj   +1 more source

Multicenter Effectiveness and Disease Stability Through 3 Years After iStentTrabecular Micro-Bypass with Phacoemulsification in Glaucoma and Ocular Hypertension

Clinical Ophthalmology, 2022
Colin Clement,1– 4 Frank Howes,5 Alexandros Ioannidis,6 Michael Shiu,7 David Manning,8 Jed A Lusthaus,3,4,9 Simon E Skalicky,10 Todd W Goodwin11 1Eye Associates, Sydney, NSW, Australia; 2Fairfield Eye Surgery, Fairfield, NSW, Australia; 3Glaucoma Unit ...
Clement C, Howes F, Ioannidis A, Shiu M, Manning D, Lusthaus JA, Skalicky SE, Goodwin TW   +7 more
doaj  

Surgical outcomes of trabecular micro-bypass minimally invasive glaucoma surgery devices in eyes with high myopia: a 24-month retrospective multicenter cohort study

Eye and Vision
Background To describe outcomes of two trabecular bypass minimally invasive glaucoma surgery (MIGS) devices in highly myopic (HM) eyes with glaucoma up to 24 months postoperatively.
Bryan Chin Hou Ang, Natalie Shi Qi Wong, Aditi Kochar, Samantha Lor, Lee Ching Phang, Hla Myint Htoon, Jeremy Tan, Mitchell Lawlor, Prasanna Venkatesh Ramesh, Younhea Jung, Zhu Li Yap, Si Rui Ng, Rachel S. Chong   +12 more
doaj   +1 more source